The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
24/7 Wall St. on MSN
3 biotech takeover targets Wall Street is watching after the Apogee deal
Quick ReadAbbVie (ABBV) proved big pharma will pay up for late-stage immunology with the Apogee deal, reigniting M&A ...
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you ...
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you ...
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...
Syndax Pharmaceuticals (NASDAQ:SNDX) posted GAAP revenue of $38.0 million in Q2 2025 and far above analyst estimates. GAAP net loss per share was $(0.83) for Q2 2025, a narrower GAAP loss than the $(1 ...
Hosted on MSN
SNDX Stock Is The Talk Of The Town Today: Here’s Everything To Know About The Latest FDA Approval
The agency approved the medicine for both adults and pediatric patients with acute myeloid leukemia who are 1 year or older and have a susceptible nucleophosmin 1 (NPM1) mutation. In the second ...
In a report released today, Bradley Canino from Guggenheim maintained a Buy rating on Syndax Pharmaceuticals, with a price target of $31.00. Deliver institutional-grade market data directly into ...
Syndax Pharmaceuticals Inc (NASDAQ:SNDX) announced topline data from the AUGMENT-101 trial of revumenib in adult and pediatric patients with relapsed/refractory (R/R) KMT2A-rearranged (KMT2Ar) acute ...
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results